A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
一项针对可切除非小细胞肺癌的新辅助顺铂、多西他赛和尼达尼布治疗的I/II期研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-4180
Cascone, Tina; Sepesi, Boris; Lin, Heather Y; Kalhor, Neda; Parra, Edwin R; Jiang, Mei; Godoy, Myrna C B; Zhang, Jianjun; Fossella, Frank V; Tsao, Anne S; Lam, Vincent K; Lu, Charles; Mott, Frank E; Simon, George R; Antonoff, Mara B; Mehran, Reza J; Rice, David C; Behrens, Carmen; Weissferdt, Annikka; Moran, Cesar; Vaporciyan, Ara A; Lee, J Jack; Swisher, Stephen G; Gibbons, Don L; Wistuba, Ignacio I; William, William N Jr; Heymach, John V